HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CFSAN 2005 Priorities Include Responding To EWG Petition

This article was originally published in The Rose Sheet

Executive Summary

Responding to a citizen petition from the Environmental Working Group requesting FDA halt the unlawful distribution of misbranded, adulterated and unlabeled cosmetics is an "A" list priority for the agency's Center for Food Safety & Applied Nutrition in fiscal 2005
Advertisement

Related Content

OCC FY 2005 “A” List Priority Accomplishments Include AHA Guidance
OCC FY 2005 “A” List Priority Accomplishments Include AHA Guidance
CFSAN Cosmetics Oversight Aided By NTP, CDER Collaboration
CFSAN Cosmetics Oversight Aided By NTP, CDER Collaboration
CIR To Consider New Data On Retinol During 2005 Review
CIR To Consider New Data On Retinol During 2005 Review
Cosmetic Claim Review Should Not Make CFSAN Priority Cut – CTFA
CIR To Consider EWG Recommendations For 2005 Ingredient Priorities
Carcinogens In Cosmetics Need Oversight, Environmental Group Claims
Carcinogens In Cosmetics Need Oversight, Environmental Group Claims
Advertisement
UsernamePublicRestriction

Register

RS012648

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel